F. Stanke-Labesque
发表
J. Cracowski,
C. Cracowski,
G. Bessard,
2001,
American journal of respiratory and critical care medicine.
F. Stanke-Labesque,
R. Guilhaumou,
E. Gautier‐Veyret,
2020,
Pharmacology & Therapeutics.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2015,
Therapeutic drug monitoring.
M. Roustit,
S. Blaise,
J. Cracowski,
2014,
Clinical pharmacology and therapeutics.
F. Stanke-Labesque,
J. Quesada,
E. Gautier‐Veyret,
2015,
Antimicrobial Agents and Chemotherapy.
J. Pépin,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2017,
Pharmacology & therapeutics.
F. Stanke-Labesque,
J. Gaulier,
D. Allorge,
2017
.
P. Devillier,
J. Cracowski,
G. Bessard,
1999,
Fundamental & clinical pharmacology.
V. Richard,
F. Stanke-Labesque,
C. Morisseau,
2021,
Scientific Reports.
F. Stanke-Labesque,
J. Alffenaar,
F. Lamoureux,
2021,
Journal of clinical medicine.
P. Devillier,
J. Cracowski,
G. Bessard,
2000
.
P. Devillier,
J. Cracowski,
O. Chavanon,
1999,
Canadian journal of physiology and pharmacology.
F. Stanke-Labesque,
M. Schnyder,
I. Burgener,
2012,
Journal of veterinary internal medicine.
R. Fanchin,
F. Stanke-Labesque,
J. Ayoubi,
2003,
Human reproduction.
F. Stanke-Labesque,
P. Kintz,
C. Bost-Bru,
2015,
Forensic science international.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2002,
Arthritis and rheumatism.
P. Lévy,
F. Stanke-Labesque,
P. Faure,
2014,
Prostaglandins, leukotrienes, and essential fatty acids.
P. Jakobsson,
F. Stanke-Labesque,
A. Avignon,
2019,
Prostaglandins & other lipid mediators.
B. Bonaz,
G. Bessard,
F. Stanke-Labesque,
2008,
Inflammatory bowel diseases.
M. Humbert,
M. Roustit,
J. Cracowski,
2014,
Clinical pharmacology and therapeutics.
J. Cracowski,
J. Mallion,
J. Baguet,
2001,
Journal of cardiovascular pharmacology.
G. Bessard,
F. Stanke-Labesque,
M. Péoc'h,
2005,
Prostaglandins & other lipid mediators.
P. Devillier,
G. Bessard,
F. Stanke-Labesque,
2001,
Arteriosclerosis, thrombosis, and vascular biology.
M. Lagarde,
M. Laville,
J. Bessard,
2008,
British Journal of Nutrition.
J. Cracowski,
G. Bessard,
J. Bessard,
2001,
Journal of chromatography. B, Biomedical sciences and applications.
P. Devillier,
J. Cracowski,
G. Bessard,
2001,
Journal of Vascular Research.
P. Devillier,
J. Cracowski,
O. Chavanon,
2000,
Journal of cardiovascular pharmacology.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2000,
Fundamental & clinical pharmacology.
J. Cracowski,
J. Baguet,
F. Tremel,
2000,
Heart.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2005,
Prostaglandins & other lipid mediators.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2005,
Free radical biology & medicine.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2001,
Clinical transplantation.
Human internal mammary artery contraction by isoprostaglandin F2α type-III (8-iso-prostaglandin F2α)
P. Devillier,
J. Cracowski,
O. Chavanon,
2000
.
G. Bessard,
F. Stanke-Labesque,
F. Caron,
2006,
Journal of hypertension.
P. Devillier,
J. Cracowski,
O. Chavanon,
2000,
Cardiovascular research.
P. Devillier,
J. Cracowski,
G. Bessard,
2002,
Journal of hypertension.
P. Devillier,
J. Cracowski,
G. Bessard,
2001,
Cardiovascular research.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2003,
Journal of cardiovascular pharmacology.
P. Devillier,
O. Chavanon,
G. Bessard,
1999,
Journal of cardiovascular pharmacology.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2003,
British journal of pharmacology.
F. Stanke-Labesque,
G. Francony,
J. Jourdil,
2018,
Clinical toxicology.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2001,
Arthritis and rheumatism.
M. Roustit,
F. Stanke-Labesque,
T. Willeman,
2021,
Clinical toxicology.
F. Stanke-Labesque,
C. Chapuis,
E. Gautier‐Veyret,
2018,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
F. Stanke-Labesque,
G. Francony,
B. Revol,
2019,
Toxicologie Analytique et Clinique.
L. Rostaing,
F. Stanke-Labesque,
Johan Noble,
2021,
Journal of clinical medicine.
F. Stanke-Labesque,
J. Guitton,
J. Tonini,
2020
.
M. Roustit,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2020,
British journal of clinical pharmacology.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2005,
Canadian journal of physiology and pharmacology.
P. Devillier,
J. Cracowski,
G. Bessard,
2002,
Journal of cardiovascular pharmacology.
F. Stanke-Labesque,
M. Bäck,
2015,
Thorax.
F. Stanke-Labesque,
S. Larrat,
V. Leroy,
2011,
Journal of hepatology.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2018,
Fundamental & clinical pharmacology.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2018,
bioRxiv.
F. Stanke-Labesque,
P. Carron,
M. Bartoli,
2010
.
F. Stanke-Labesque,
J. Jourdil,
M. Bartoli,
2009,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2002,
Arteriosclerosis, thrombosis, and vascular biology.
J. Cracowski,
O. Chavanon,
G. Bessard,
2002
.
D. Concordet,
B. Mourvillier,
C. Schwebel,
2021,
Clinical pharmacology and therapeutics.
F. Stanke-Labesque,
S. Halimi,
P. Benhamou,
2010,
Diabetologia.
G. Bessard,
F. Stanke-Labesque,
M. Mallaret,
2004,
Cardiovascular research.
F. Stanke-Labesque,
M. Mallaret,
J. Jourdil,
2019,
Forensic Toxicology.
P. Devillier,
J. Cracowski,
O. Chavanon,
1999,
Journal of cardiovascular pharmacology.
M. Roustit,
F. Stanke-Labesque,
P. Leclercq,
2008,
British journal of clinical pharmacology.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2012,
European Respiratory Journal.
P. Marquet,
F. Stanke-Labesque,
G. Babany,
2009,
Fundamental & clinical pharmacology.
G. Bessard,
F. Stanke-Labesque,
S. Larrat,
2003,
Antimicrobial Agents and Chemotherapy.
G. Bessard,
F. Stanke-Labesque,
S. Larrat,
2002
.
F. Stanke-Labesque,
J. Tonini,
J. Jourdil,
2013,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
F. Stanke-Labesque,
E. Gautier‐Veyret,
A. Thiébaut-Bertrand,
2022,
Journal of clinical medicine.
S. Bailly,
F. Stanke-Labesque,
P. Gandia,
2020,
Fundamental & clinical pharmacology.
F. Stanke-Labesque,
P. Bedouch,
E. Gautier‐Veyret,
2020,
British journal of clinical pharmacology.
M. Roustit,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2019,
Antimicrobial Agents and Chemotherapy.
F. Stanke-Labesque,
E. Gautier‐Veyret,
J. Jourdil,
2018,
Therapeutic drug monitoring.
A. Thiébaut,
F. Stanke-Labesque,
J. Tonini,
2012,
Antimicrobial Agents and Chemotherapy.
F. Stanke-Labesque,
J. Gaulier,
D. Allorge,
2018,
Drug testing and analysis.
J. Cracowski,
O. Chavanon,
G. Bessard,
2002,
British journal of pharmacology.
J. Cracowski,
G. Bessard,
F. Stanke-Labesque,
2000,
La Revue de medecine interne.
P. Marquet,
F. Stanke-Labesque,
G. Babany,
2009,
Gastroenterologie clinique et biologique.
F. Stanke-Labesque,
C. Solas,
S. Quaranta,
2011,
Therapie.
F. Stanke-Labesque,
J. Jourdil,
V. Scolan,
2018,
Toxicologie Analytique et Clinique.
P. Devillier,
J. Cracowski,
O. Chavanon,
2000
.
F. Stanke-Labesque,
P. Faure,
S. Halimi,
2014,
Diabetes & metabolism.
G. Bessard,
F. Stanke-Labesque,
G. Hardy,
2004,
Therapie.
L. Rostaing,
F. Stanke-Labesque,
Johan Noble,
2022,
Clinical Biochemistry.
P. Devillier,
G. Bessard,
F. Stanke-Labesque,
2000,
Journal of cardiovascular pharmacology.
U. Christians,
F. Stanke-Labesque,
J. Jourdil,
2021,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
L. Rostaing,
F. Stanke-Labesque,
Johan Noble,
2020,
Transplantation.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2015,
Prostaglandins & other lipid mediators.
Edouard F. Bonneville,
F. Stanke-Labesque,
M. Baudrant,
2020,
British journal of clinical pharmacology.
M. Roustit,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2021,
Pharmaceutics.
F. Stanke-Labesque,
F. Paysant,
N. Allibe,
2021,
International Journal of Legal Medicine.
F. Stanke-Labesque,
P. Kintz,
V. Scolan,
2017,
Current pharmaceutical design.
G. Bessard,
F. Stanke-Labesque,
M. Pérault-Pochat,
2001
.
B. Bonaz,
S. Bailly,
F. Stanke-Labesque,
2019,
British journal of clinical pharmacology.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2018,
Pharmacological research.
F. Stanke-Labesque,
A. Benetos,
C. Labat,
2016
.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2009,
ILAR journal.
P. Lévy,
G. Bessard,
F. Stanke-Labesque,
2005,
Journal of applied physiology.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2012,
Frontiers in bioscience.
B. Bonaz,
F. Stanke-Labesque,
F. Lemaitre,
2017,
Analytical and Bioanalytical Chemistry.
F. Stanke-Labesque,
E. Gautier‐Veyret,
T. Debillon,
2022,
Antimicrobial agents and chemotherapy.
F. Stanke-Labesque,
E. Gautier‐Veyret,
P. Malvezzi,
2020,
Clinical biochemistry.
F. Stanke-Labesque,
P. Picard,
S. Auger,
2013,
Analytica chimica acta.
G. Bessard,
F. Stanke-Labesque,
F. Bayle,
2004,
European Journal of Clinical Pharmacology.
J. Pépin,
G. Leftheriotis,
S. Perrig,
2014,
Mediators of inflammation.
P. Lévy,
G. Bessard,
F. Stanke-Labesque,
2006,
Respiratory Physiology & Neurobiology.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2009,
The Journal of allergy and clinical immunology.
P. Marquet,
F. Stanke-Labesque,
F. Sauvage,
2009,
Therapeutic drug monitoring.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2014,
Cardiovascular research.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2014
.
P. Devillier,
J. Cracowski,
O. Chavanon,
2000,
European journal of pharmacology.
M. Roustit,
J. Baguet,
P. Lévy,
2008,
European Respiratory Journal.
J. Pépin,
P. Lévy,
F. Stanke-Labesque,
2012,
Journal of Lipid Research.
Variability of rituximab and tocilizumab trough concentrations in patients with rheumatoid arthritis
J. Gottenberg,
F. Stanke-Labesque,
A. Baillet,
2021,
Fundamental & clinical pharmacology.
B. Bonaz,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2019,
Analytica chimica acta.
J. Cracowski,
J. Mallion,
G. Bessard,
2003,
Hypertension.
S. Bailly,
F. Stanke-Labesque,
E. Gautier‐Veyret,
2017,
Pharmacogenomics.
F. Stanke-Labesque,
L. Payen,
M. Chenel,
2021,
Pharmaceutical Research.
F. Stanke-Labesque,
E. Gautier‐Veyret,
X. Fonrose,
2017,
Clinical pharmacology and therapeutics.
F. Stanke-Labesque,
V. Scolan,
F. Paysant,
2023,
Journal of Analytical Toxicology.
F. Stanke-Labesque,
B. Revol,
N. Fouilhé,
2022,
Toxicologie Analytique et Clinique.
F. Stanke-Labesque,
E. Gautier‐Veyret,
F. Thomas,
2023,
British Journal of Clinical Pharmacology.
C. Bisbal,
F. Stanke-Labesque,
A. Avignon,
2016,
PloS one.
M. Roustit,
J. Cracowski,
F. Stanke-Labesque,
2017,
Journal of clinical pharmacology.
F. Stanke-Labesque,
J. Quesada,
E. Gautier‐Veyret,
2015,
Antimicrobial Agents and Chemotherapy.
P. Lévy,
F. Stanke-Labesque,
P. Faure,
2014,
Prostaglandins, leukotrienes, and essential fatty acids.